These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 29900542

  • 1. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL, Muls N, van Pesch V.
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [Abstract] [Full Text] [Related]

  • 2. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
    Gurtner KM, Shosha E, Bryant SC, Andreguetto BD, Murray DL, Pittock SJ, Willrich MAV.
    Clin Chem Lab Med; 2018 Jun 27; 56(7):1071-1080. PubMed ID: 29455184
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
    Ferraro D, Trovati A, Bedin R, Natali P, Franciotta D, Santangelo M, Camera V, Vitetta F, Varani M, Trenti T, Gastaldi M, De Biasi S, Nasi M, Pinti M, Meletti S, Sola P.
    Eur J Neurol; 2020 Mar 27; 27(3):461-467. PubMed ID: 31710409
    [Abstract] [Full Text] [Related]

  • 4. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P, Konen FF, Wurster U, Jendretzky KF, Gingele S, Sühs KW, Pul R, Witte T, Stangel M, Skripuletz T.
    Int J Mol Sci; 2018 Nov 29; 19(12):. PubMed ID: 30501024
    [Abstract] [Full Text] [Related]

  • 5. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.
    Süße M, Hannich M, Petersmann A, Zylla S, Pietzner M, Nauck M, Dressel A.
    Eur J Neurol; 2018 Sep 29; 25(9):1134-1139. PubMed ID: 29683546
    [Abstract] [Full Text] [Related]

  • 6. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
    Hassan-Smith G, Durant L, Tsentemeidou A, Assi LK, Faint JM, Kalra S, Douglas MR, Curnow SJ.
    J Neuroimmunol; 2014 Nov 15; 276(1-2):175-9. PubMed ID: 25146968
    [Abstract] [Full Text] [Related]

  • 7. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
    Huss A, Mojib-Yezdani F, Bachhuber F, Fangerau T, Lewerenz J, Otto M, Tumani H, Senel M.
    Clin Chim Acta; 2019 Nov 15; 498():148-153. PubMed ID: 31437445
    [Abstract] [Full Text] [Related]

  • 8. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M, Mojib-Yezdani F, Braisch U, Bachhuber F, Lewerenz J, Ludolph AC, Otto M, Tumani H.
    Front Immunol; 2019 Nov 15; 10():641. PubMed ID: 30984199
    [Abstract] [Full Text] [Related]

  • 9. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
    Presslauer S, Milosavljevic D, Brücke T, Bayer P, Hübl W.
    J Neurol; 2008 Oct 15; 255(10):1508-14. PubMed ID: 18685917
    [Abstract] [Full Text] [Related]

  • 10. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
    Kaplan B, Golderman S, Yahalom G, Yeskaraev R, Ziv T, Aizenbud BM, Sela BA, Livneh A.
    J Immunol Methods; 2013 Apr 30; 390(1-2):74-80. PubMed ID: 23376556
    [Abstract] [Full Text] [Related]

  • 11. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.
    Valencia-Vera E, Martinez-Escribano Garcia-Ripoll A, Enguix A, Abalos-Garcia C, Segovia-Cuevas MJ.
    Clin Chem Lab Med; 2018 Mar 28; 56(4):609-613. PubMed ID: 29087953
    [Abstract] [Full Text] [Related]

  • 12. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis.
    Fischer C, Arneth B, Koehler J, Lotz J, Lackner KJ.
    Clin Chem; 2004 Oct 28; 50(10):1809-13. PubMed ID: 15271859
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
    Christiansen M, Gjelstrup MC, Stilund M, Christensen T, Petersen T, Jon Møller H.
    Clin Chem Lab Med; 2018 Dec 19; 57(2):210-220. PubMed ID: 30055097
    [Abstract] [Full Text] [Related]

  • 14. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.
    Desplat-Jégo S, Feuillet L, Pelletier J, Bernard D, Chérif AA, Boucraut J.
    J Clin Immunol; 2005 Jul 19; 25(4):338-45. PubMed ID: 16133990
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.
    Hegen H, Berek K, Deisenhammer F.
    Wien Med Wochenschr; 2022 Nov 19; 172(15-16):337-345. PubMed ID: 35133530
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
    Makshakov G, Nazarov V, Kochetova O, Surkova E, Lapin S, Evdoshenko E.
    PLoS One; 2015 Nov 19; 10(11):e0143375. PubMed ID: 26606531
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
    Gaetani L, Di Carlo M, Brachelente G, Valletta F, Eusebi P, Mancini A, Gentili L, Borrelli A, Calabresi P, Sarchielli P, Ferri C, Villa A, Di Filippo M.
    J Neuroimmunol; 2020 Feb 15; 339():577108. PubMed ID: 31743879
    [Abstract] [Full Text] [Related]

  • 18. [Clinical usefulness of oligoclonal bands].
    Falip M, Tintoré M, Jardí R, Duran I, Link H, Montalbán X.
    Rev Neurol; 2020 Feb 15; 32(12):1120-4. PubMed ID: 11562840
    [Abstract] [Full Text] [Related]

  • 19. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
    Hegen H, Walde J, Berek K, Arrambide G, Gnanapavan S, Kaplan B, Khalil M, Saadeh R, Teunissen C, Tumani H, Villar LM, Willrich MAV, Zetterberg H, Deisenhammer F.
    Mult Scler; 2023 Feb 15; 29(2):169-181. PubMed ID: 36453167
    [Abstract] [Full Text] [Related]

  • 20. Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis.
    Agnello L, Lo Sasso B, Salemi G, Altavilla P, Pappalardo EM, Caldarella R, Meli F, Scazzone C, Bivona G, Ciaccio M.
    Lab Med; 2020 Jul 08; 51(4):402-407. PubMed ID: 31943078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.